Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE

Summary

Study Title A phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and preliminary efficacy of KPG-818 in patients with mild to moderate systemic lupus erythematosus

Timeline

Start

2021-06-03

Primary completion

2023-08-18

Completion

2023-08-18

Drugs

Indications